This website uses cookies to ensure functionality for better navigation.
By continuing to browse, you consent to the use of cookies and the new terms and conditions of privacy.

I accept

Competence | quality | credibility

To meet our Partners’ Needs

LEF's Institutional video


Import of medicines

​​​Download the most recent newsletter to know how can we collaborate with your company in the import of medicines' area.




The hemp authorization regime for industrial purposes has recently been published. This publication has long been claimed by the industry and clarifies the control functions: IFAP with PJ, GNR and PSP - in the case of hemp cultivation for industrial purposes, including for food and animal feed - and DGAV - in designing the industrial hemp cultivation authorization.

COVID-19: Measures implemented at LEF

​​LEF, in compliance with the standards issued by the portuguese authorities, aims to maintain its normal functioning as far as possible, with the adoption of preventive and contingency measures. We have been making efforts to minimize the negative impacts on our busine​ss, customers, employees and other partners. Learn more about the set of measures implemented by LEF in the letter ​sent to all partners.

Nitrosamines - New deadline for risk assessment

​​​The deadline for submitting the results of drug products risk assessment containing chemically synthesized active substances (step 1) has been extended from 26 March to 1 October 2020! LEF has a customized consultancy service ready to answer this regulatory challenge.

Cannabis - Implementation of legal requirements

​​​​LEF has an integrated service offer for the medicinal cannabis market, assisting in the implementation of GACP, GMP, GDP and quality control analysis in accordance with current requirements. ​​​Contact LEF for more information!